Jump to content

Ultrasound-enhanced systemic thrombolysis

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CitationCleanerBot (talk | contribs) at 06:41, 8 November 2016 (→‎Ultrasound-Accelerated Thrombolysis (Catheter-based): clean up, url redundant with pmc, add pmc, and/or remove accessdate if no url using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ultrasound-Enhanced Systemic Thrombolysis is a medical technology that utilizes transcranial doppler ultrasonography to treat stroke-causing blood clots. It is thought that transcranial doppler ultrasonography aimed at residual obstructive intracranial blood flow may help expose thrombi to tissue plasminogen activator or other thrombolytic drugs.

Studies have shown that complete recanalisation or dramatic clinical recovery can be increased by more than 19% when using transcranial doppler ultrasonography.

Ultrasound-Accelerated Thrombolysis (Catheter-based)

A recent multicenter randomized trial (DUET[1]) compared standard catheter-directed thrombolysis (CDT) versus ultrasound-accelerated thrombolysis (USAT, EKOS Corporation) for the treatment of acute peripheral arterial thrombotic occlusions. Results showed that, on average, patients treated with USAT were completed 12 hours sooner than those treated with standard CDT with no increase in "serious adverse events."[2] Plans are underway to commence the DUET II study, which will be a non-randomized trial using the EKOS system with an even lower hourly drug dose with an expectation of further reducing bleeding complications.

See also

References

  1. ^ Schrijver, AM; et al. (2011). "Dutch randomized trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thromboembolic infrainguinal disease (DUET): design and rationale". Trials. 12: 20. doi:10.1186/1745-6215-12-20. PMID 21255459.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  2. ^ Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions, EKOS Corporation/Bothell, WA. www.ekoscorp.com (April 15, 2013). Retrieved on April 19, 2013.


Stub icon

This medical treatment–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ultrasound-enhanced_systemic_thrombolysis&oldid=748447760"